Aether Biomachines

Aether Biomachines is a private, Palo Alto-based company founded in 2019, positioning itself at the intersection of AI and synthetic biology to reindustrialize American manufacturing. It has developed a proprietary Protein Function Model trained on massive, in-house experimental data to predict and design proteins with novel functions for materials science and critical mineral processing. The company has launched initial commercial products for additive manufacturing, raised a $15M funding round, and is developing a pipeline of advanced materials and extraction technologies, targeting defense, aerospace, and industrial sectors.

Proprietary 'Protein Function Model' AI trained on massive in-house experimental data from a robotic high-throughput screening lab, enabling the predictable design of novel proteins for industrial functions.

Aether competes with other AI-driven protein design companies like Ginkgo Bioworks (which has a broader platform focus) and Arzeda. In advanced materials, it faces competition from large chemical companies (e.g., BASF, Dow) and specialized 3D printing material vendors. In critical mineral processing, it competes with traditional mining/chemical firms and new extraction technology startups.